Form POS AM - Post-Effective amendments for registration statement:
SEC Accession No. 0001193125-24-267199
Filing Date
2024-11-27
Accepted
2024-11-27 16:30:25
Documents
4

Document Format Files

Seq Description Document Type Size
1 POS AM d898490dposam.htm POS AM 420399
2 EX-23.1 d898490dex231.htm EX-23.1 1726
3 EX-23.2 d898490dex232.htm EX-23.2 1906
4 GRAPHIC g898490g82a30.jpg GRAPHIC 34111
  Complete submission text file 0001193125-24-267199.txt   472353
Mailing Address THREE INTERNATIONAL TOWERS LEVEL 24, 300 BARANGAROO AVENUE SYDNEY NSW C3 2000
Business Address THREE INTERNATIONAL TOWERS LEVEL 24, 300 BARANGAROO AVENUE SYDNEY NSW C3 2000 01161298780088
KAZIA THERAPEUTICS LTD (Filer) CIK: 0001075880 (see all company filings)

EIN.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: POS AM | Act: 33 | File No.: 333-279773 | Film No.: 241511669
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)